Assessment of air pollutants removal by green infrastructure and urban and peri-urban forests management for a greening plan in the Municipality of Ferrara (Po river plain, Italy)

Air pollution is a serious concern for human health and is even more worrying in areas that are known to be "pollution hotspots", such as the Po Plain in northern Italy. The Urban Green Infrastructure (UGI), which includes urban and peri-urban forests, enhances human health and wellbeing delivering a wide range of ecosystem services, including air quality improvement. In this research, we analyzed, in biophysical and monetary terms, the role of the UGI in removing PM10 and O-3 from the atmosphere in the Municipality of Ferrara using established removal models. We used a multiscale approach that includes geospatial data, field sampling and laboratory analysis. Then, using a local green areas database, we located public areas that could potentially undergo forestation actions without requiring any land conversion and evaluated the benefit in terms of ESs provision that these actions may exert. We found that, in 2019, the UGI in the Municipality of Ferrara removed about 19.8 Mg of PM10 and 8.6 Mg of O-3, for a monetary benefit of (sic) 2.12 million (sic) and 147*103 respectively. We then identified about 121 ha within the urban core of the Municipality that could potentially be forested. Such an action would increase the PM10 and O-3 removal by about 49% and 18%, respectively. Our findings comply with the EU Biodiversity strategy for 2030, which calls for the development of an ambitious greening plan for cities with more than 20,000 inhabitants

The Changing Landscape for Stroke\ua0Prevention in AF: Findings From the GLORIA-AF Registry Phase 2

Background GLORIA-AF (Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation) is a prospective, global registry program describing antithrombotic treatment patterns in patients with newly diagnosed nonvalvular atrial fibrillation at risk of stroke. Phase 2 began when dabigatran, the first non\u2013vitamin K antagonist oral anticoagulant (NOAC), became available. Objectives This study sought to describe phase 2 baseline data and compare these with the pre-NOAC era collected during phase 1. Methods During phase 2, 15,641 consenting patients were enrolled (November 2011 to December 2014); 15,092 were eligible. This pre-specified cross-sectional analysis describes eligible patients\u2019 baseline characteristics. Atrial fibrillation disease characteristics, medical outcomes, and concomitant diseases and medications were collected. Data were analyzed using descriptive statistics. Results Of the total patients, 45.5% were female; median age was 71 (interquartile range: 64, 78) years. Patients were from Europe (47.1%), North America (22.5%), Asia (20.3%), Latin America (6.0%), and the Middle East/Africa (4.0%). Most had high stroke risk (CHA2DS2-VASc [Congestive heart failure, Hypertension, Age  6575 years, Diabetes mellitus, previous Stroke, Vascular disease, Age 65 to 74 years, Sex category] score  652; 86.1%); 13.9% had moderate risk (CHA2DS2-VASc = 1). Overall, 79.9% received oral anticoagulants, of whom 47.6% received NOAC and 32.3% vitamin K antagonists (VKA); 12.1% received antiplatelet agents; 7.8% received no antithrombotic treatment. For comparison, the proportion of phase 1 patients (of N = 1,063 all eligible) prescribed VKA was 32.8%, acetylsalicylic acid 41.7%, and no therapy 20.2%. In Europe in phase 2, treatment with NOAC was more common than VKA (52.3% and 37.8%, respectively); 6.0% of patients received antiplatelet treatment; and 3.8% received no antithrombotic treatment. In North America, 52.1%, 26.2%, and 14.0% of patients received NOAC, VKA, and antiplatelet drugs, respectively; 7.5% received no antithrombotic treatment. NOAC use was less common in Asia (27.7%), where 27.5% of patients received VKA, 25.0% antiplatelet drugs, and 19.8% no antithrombotic treatment. Conclusions The baseline data from GLORIA-AF phase 2 demonstrate that in newly diagnosed nonvalvular atrial fibrillation patients, NOAC have been highly adopted into practice, becoming more frequently prescribed than VKA in Europe and North America. Worldwide, however, a large proportion of patients remain undertreated, particularly in Asia and North America. (Global Registry on Long-Term Oral Antithrombotic Treatment in Patients With Atrial Fibrillation [GLORIA-AF]; NCT01468701

Aquatic Vegetation Loss and Its Implication on Climate Regulation in a Protected Freshwater Wetland of Po River Delta Park (Italy)

Aquatic vegetation loss caused substantial decrease of ecosystem processes and services during the last decades, particularly for the capacity of these ecosystems to sequester and store carbon from the atmosphere. This study investigated the extent of aquatic emergent vegetation loss for the period 1985–2018 and the consequent effects on carbon sequestration and storage capacity of Valle Santa wetland, a protected freshwater wetland dominated by Phragmites australis located in the Po river delta Park (Northern Italy), as a function of primary productivity and biomass decomposition, assessed by means of satellite images and experimental measures. The results showed an extended loss of aquatic vegetated habitats during the considered period, with 1989 being the year with higher productivity. The mean breakdown rates of P. australis were 0.00532 d−1 and 0.00228 d−1 for leaf and stem carbon content, respectively, leading to a predicted annual decomposition of 64.6% of the total biomass carbon. For 2018 the carbon sequestration capacity was estimated equal to 0.249 kg C m−2 yr−1, while the carbon storage of the whole wetland was 1.75 × 103 t C (0.70 kg C m−2). Nonetheless, despite the protection efforts over time, the vegetation loss occurred during the last decades significantly decreased carbon sequestration and storage by 51.6%, when comparing 2018 and 1989. No statistically significant effects were found for water descriptors. This study demonstrated that P. australis-dominated wetlands support important ecosystem processes and should be regarded as an important carbon sink under an ecosystem services perspective, with the aim to maximize their capacity to mitigate climate change

Aquatic Vegetation Loss and Its Implication on Climate Regulation in a Protected Freshwater Wetland of Po River Delta Park (Italy)

Aquatic vegetation loss caused substantial decrease of ecosystem processes and services during the last decades, particularly for the capacity of these ecosystems to sequester and store carbon from the atmosphere. This study investigated the extent of aquatic emergent vegetation loss for the period 1985–2018 and the consequent effects on carbon sequestration and storage capacity of Valle Santa wetland, a protected freshwater wetland dominated by Phragmites australis located in the Po river delta Park (Northern Italy), as a function of primary productivity and biomass decomposition, assessed by means of satellite images and experimental measures. The results showed an extended loss of aquatic vegetated habitats during the considered period, with 1989 being the year with higher productivity. The mean breakdown rates of P. australis were 0.00532 d−1 and 0.00228 d−1 for leaf and stem carbon content, respectively, leading to a predicted annual decomposition of 64.6% of the total biomass carbon. For 2018 the carbon sequestration capacity was estimated equal to 0.249 kg C m−2 yr−1, while the carbon storage of the whole wetland was 1.75 × 103 t C (0.70 kg C m−2). Nonetheless, despite the protection efforts over time, the vegetation loss occurred during the last decades significantly decreased carbon sequestration and storage by 51.6%, when comparing 2018 and 1989. No statistically significant effects were found for water descriptors. This study demonstrated that P. australis-dominated wetlands support important ecosystem processes and should be regarded as an important carbon sink under an ecosystem services perspective, with the aim to maximize their capacity to mitigate climate change

Correction to: Comparative effectiveness and safety of non-vitamin K antagonists for atrial fibrillation in clinical practice: GLORIA-AF Registry

International audienceIn this article, the name of the GLORIA-AF investigator Anastasios Kollias was given incorrectly as Athanasios Kollias in the Acknowledgements. The original article has been corrected

Patterns of oral anticoagulant use and outcomes in Asian patients with atrial fibrillation: a post-hoc analysis from the GLORIA-AF Registry

Background: Previous studies suggested potential ethnic differences in the management and outcomes of atrial fibrillation (AF). We aim to analyse oral anticoagulant (OAC) prescription, discontinuation, and risk of adverse outcomes in Asian patients with AF, using data from a global prospective cohort study. Methods: From the GLORIA-AF Registry Phase II-III (November 2011-December 2014 for Phase II, and January 2014-December 2016 for Phase III), we analysed patients according to their self-reported ethnicity (Asian vs. non-Asian), as well as according to Asian subgroups (Chinese, Japanese, Korean and other Asian). Logistic regression was used to analyse OAC prescription, while the risk of OAC discontinuation and adverse outcomes were analysed through Cox-regression model. Our primary outcome was the composite of all-cause death and major adverse cardiovascular events (MACE). The original studies were registered with ClinicalTrials.gov, NCT01468701, NCT01671007, and NCT01937377. Findings: 34,421 patients were included (70.0 ± 10.5 years, 45.1% females, 6900 (20.0%) Asian: 3829 (55.5%) Chinese, 814 (11.8%) Japanese, 1964 (28.5%) Korean and 293 (4.2%) other Asian). Most of the Asian patients were recruited in Asia (n = 6701, 97.1%), while non-Asian patients were mainly recruited in Europe (n = 15,449, 56.1%) and North America (n = 8378, 30.4%). Compared to non-Asian individuals, prescription of OAC and non-vitamin K antagonist oral anticoagulant (NOAC) was lower in Asian patients (Odds Ratio [OR] and 95% Confidence Intervals (CI): 0.23 [0.22-0.25] and 0.66 [0.61-0.71], respectively), but higher in the Japanese subgroup. Asian ethnicity was also associated with higher risk of OAC discontinuation (Hazard Ratio [HR] and [95% CI]: 1.79 [1.67-1.92]), and lower risk of the primary composite outcome (HR [95% CI]: 0.86 [0.76-0.96]). Among the exploratory secondary outcomes, Asian ethnicity was associated with higher risks of thromboembolism and intracranial haemorrhage, and lower risk of major bleeding. Interpretation: Our results showed that Asian patients with AF showed suboptimal thromboembolic risk management and a specific risk profile of adverse outcomes; these differences may also reflect differences in country-specific factors. Ensuring integrated and appropriate treatment of these patients is crucial to improve their prognosis. Funding: The GLORIA-AF Registry was funded by Boehringer Ingelheim GmbH